Molecules 2009, 14
3026
1
IR (cm-1) 2927, 1767, 1687, 1401, 1284, 1187, 1153, 1027; H-NMR (CDCl3), δ: 4.66 (dd, 1H,
J1=5.0 Hz, J2=10.6 Hz, CH), 4.16 (q, 2H, J=7.1 Hz, OCH2), 3.50 (t, 2H, J=7.2 Hz, NCH2), 3.54–3.29
(m, 2H, CH2pyrr.), 2.70 (s, 4H, OCCH2CH2CO), 2.42 (t, 2H, J=8.0 Hz, CH2pyrr.), 2.17–1.95 (m, 2H,
CH2pyrr. and 1H from CH2CH), 1.78–1.56 (m, 2H, CH2 and 1H from CH2CH), 1.34–1.28 (m, 2H,
CH2), 1.26 (t, 3H, J=7.1 Hz, CH3); 13C-NMR (CDCl3), δ: 177.13, 175.78, 170.76, 61.12, 53.51, 43.53,
38.26, 30.73, 28.08, 27.03, 23.35, 18.21, 14.07; HR-MS: for C16H25O5N2 [M+H]+ calculated 325.1758
m/z, found 325.1757 m/z.
Ethyl-6-(2,5-dioxopyrrolidin-1-yl)-2-(2-oxopiperidin-1-yl)hexanoate (3e): For the coupling of
piperidin-2-one and compound 2 the conditions of Method A and Method B were used. Yield: 0%
(Method A), 72% (Method B): a light yellow oil; RF 0.27 (EtOAc/petroleum ether 10:1 + 1% TEA);
1
IR (cm-1) 2941, 2868, 1698, 1637, 1401, 1347, 1178; H-NMR (CDCl3), δ: 5.14 (dd, J=10.3, 5.3 Hz,
1H, CH), 4.24–4.06 (m, 2H, OCH2), 3.50 (t, J=7.1 Hz, 2H, NCH2), 3.29–3.17 (m, 2H, NCH2pip.), 2.70
(s, 4H, OCCH2CH2CO), 2.48–2.42 (m, 2H, OCCH2pip.), 2.01–1.53 (m, 8H, CH2), 1.37–1.23 (m, 2H,
CH2), 1.26 (t, J=7.2 Hz, 3H, CH3); 13C-NMR (CDCl3), δ: 177.13, 171.16, 170.47, 61.00, 55.72, 44.13,
38.42, 32.21, 28.13, 27.48, 27.22, 23.46, 23.12, 20.98, 14.15; HR-MS: for C17H27O5N2 [M+H]+
calculated 339.1914 m/z, found 339.1914 m/z.
Ethyl-6-(2,5-dioxopyrrolidin-1-yl)-2-(2-oxoazepan-1-yl)hexanoate (3f): For the coupling of azepan-2-
one and compound 2 the conditions of Method A and Method B were used. Yield: 0% (Method A),
68% (Method B); a light yellow oil; RF 0.27 (AcOEt/petroleum ether + 1% TEA); IR (cm-1) 2937,
1
2863, 1695, 1674, 1401, 1156; H-NMR (CDCl3), δ: 5.10 (dd, J1=9.9 Hz, J2=5.1 Hz, 1H, CH),
4.33–4.00 (m, 2H, OCH2), 3.50 (t, J=7.2 Hz, 2H, NCH2), 3.41–3.15 (m, 2H, NCH2azep.), 2.71 (s, 4H,
OCCH2CH2CO), 2.64–2.51 (m, 2H, OCCH2azep.), 2.05–1.90 (m, 2H, CH2), 1.85–1.45 (m, 8H, CH2),
13
1.39–1.27 (m, 2H, CH2), 1.26 (t, J=6.6 Hz, 3H, CH3); C-NMR (CDCl3), δ: 177.18, 176.22, 171.47,
60.97, 57.06, 46.19, 38.41, 37.28, 29.91, 28.63, 28.11, 27.29, 23.46, 23.25, 14.12; HR-MS: for
C18H29O5N2 [M+H]+ calculated 353.2071 m/z, found 353.2071 m/z.
Ethyl-6-(2,5-dioxopyrrolidin-1-yl)-2-(4-oxopiperidin-1-yl)hexanoate (3g): For the coupling of
piperidin-2-one and compound 2 the conditions of Method A and Method B were used. Yield: 81%
(Method A); 83% (Method B); a light orange oil; RF 0.59 (CH2Cl2/MeOH 95:5); IR (cm-1) 2941, 2865,
2822, 1697, 1401, 1344, 1159; 1H-NMR (CDCl3), δ: 4.16 (q, J=7.1 Hz, 2H, OCH2), 3.52 (t, J=7.1 Hz,
2H, NCH2), 3.31 (t, J=7.5 Hz, 1H, CH), 3.04–2.76 (m, 4H, NCH2), 2.71 (s, 4H, OCCH2CH2CO),
13
2.51–2.34 (m, 4H, CH2COCH2), 1.80–1.33 (m, 6H, CH2), 1.28 (t, J=7.1 Hz, 3H, CH3); C-NMR
(CDCl3), δ: 208.75, 177.09, 171.72, 66.51, 60.27, 48.97, 41.95, 38.51, 28.95, 28.11, 27.29, 23.50,
14.42; HR-MS: for C17H27O5N2 [M+H]+ calculated 339.1914 m/z, found 339.1915 m/z.
Ethyl-2,6-bis(2,5-dioxopyrrolidin-1-yl)hexanoate (3h): For the coupling of pyrrolidin-2,5-dione and
compound 2 the conditions of Method A and Method B were used. Yield: 0% (Method A), 66%
(Method B); a white crystalline compound; Mp 99–101 °C; RF 0.35 (EtOAc); IR (cm-1) 2980, 2940,
1
1690, 1391, 1253, 1190; H-NMR (CDCl3), δ: 4.62 (dd, J1=9.4 Hz, J2=5.8 Hz, 1H, CH), 4.19 (dq,
J1=7.1 Hz, J2=1.6 Hz, 2H, OCH2), 3.47 (t, J=7.1 Hz, 2H), 2.79 (s, 4H, OCCH2CH2CO), 2.70 (s, 4H,